Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib: a review of its use in patients with radioactive iodine-refractory, metastatic differentiated thyroid carcinoma
Authors
Keywords
Sorafenib, Differentiated thyroid carcinoma, Radioactive iodine
Journal
Targeted Oncology
Volume 10, Issue 1, Pages 171-178
Publisher
Springer Nature
Online
2015-03-06
DOI
10.1007/s11523-015-0363-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response to sorafenib treatment in advanced metastatic thyroid cancer
- (2014) Fabian Pitoia Arquivos Brasileiros de Endocrinologia e Metabologia
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
- (2014) Marcia S Brose et al. LANCET
- Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer
- (2014) R. Dadu et al. ONCOLOGIST
- Sorafenib in Metastatic Thyroid Cancer: A Systematic Review
- (2014) L. Thomas et al. ONCOLOGIST
- Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
- (2014) Daniel McFarland et al. OncoTargets and Therapy
- Sorafenib and Thyroid Cancer
- (2013) Poupak Fallahi et al. BIODRUGS
- An update on clinical trials of targeted therapies in thyroid cancer
- (2013) Sigurdis Haraldsdottir et al. CURRENT OPINION IN ONCOLOGY
- Targeted therapy in thyroid cancer
- (2013) Iain J. Nixon et al. Current Opinion in Otolaryngology & Head and Neck Surgery
- Evolving Approaches in Managing Radioactive Iodine-Refractory Differentiated Thyroid Cancer
- (2013) Wendy Sacks et al. Endocrine Practice
- Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis
- (2013) Chen-Tian Shen et al. ENDOCRINE-RELATED CANCER
- Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial
- (2012) T C Schneider et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer
- (2011) Marcia S Brose et al. BMC CANCER
- Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population
- (2011) Merina Ahmed et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor Therapy
- (2009) N. S. Azad et al. CLINICAL CANCER RESEARCH
- 51LBA Completion of a Phase II study of sorafenib for advanced thyroid cancer
- (2009) M.S. Brose et al. EJC SUPPLEMENTS
- Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
- (2009) Hendrieke Hoftijzer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
- Risk of hand-foot skin reaction with sorafenib: A systematic review and meta-analysis
- (2008) David Chu et al. ACTA ONCOLOGICA
- Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
- (2008) Hironobu Minami et al. CANCER SCIENCE
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started